M.HamelR.KrzakG.PluchinoS
V quy trnh sn xut: sn phm c iu ch ti cng ty CP Dc Phm Oshii, thuc 64 c s nh my H Ni t tiu chun Thc hnh sn xut tt GMP, hin c s chng nhn l 101/2019/ATTP-CNGMP cp ngy 21/11/2019
Multimodal therapeutic approaches, integrating techniques such as chemotherapy, photodynamic therapy, gene delivery, radiotherapy, and immunotherapy, are essential for GBM management, enabling synergistic effects, targeted drug release, and enhanced penetration across the bloodbrain barrier, with MSNs facilitating precise co-delivery of therapeutic agents, stimuli-responsive activation, and real-time monitoring to optimize treatment efficacy and overcome tumor heterogeneity
Suggested usage rate: 0.1-2%